Evidence map›Paper›PMID 36125124›Full record

ReviewACS chemical neuroscience2022

Could Amyloid-β 1-42 or α-Synuclein Interact Directly with Mitochondrial DNA? A Hypothesis.

Duygu Gezen-Ak, Zuhal Yurttaş, Tugay Çamoǧlu, Erdinç Dursun

Open access · hybridAbstract readReview
In one paragraph

Review in ACS chemical neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Biological Amyloids Chemically Damage DNA.ACS chemical neuroscience · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Duygu Gezen-AkDepartment of Neuroscience, Institute of Neurological Sciences, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.
Zuhal YurttaşDepartment of Neuroscience, Institute of Neurological Sciences, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.
Tugay ÇamoǧluDepartment of Neuroscience, Institute of Neurological Sciences, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.
Erdinç DursunDepartment of Neuroscience, Institute of Neurological Sciences, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.ORCID 0000-0003-3701-6674
Istanbul University-Cerrahpaşa · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The amyloid β (Aβ) and the α-synuclein (α-syn) are shown to be translocated into mitochondria. Even though their roles are widely investigated in pathological conditions, information on the presence and functions of Aβ and α-syn in mitochondria in endogenous levels is somewhat limited. We hypothesized that endogenous Aβ fragments or α-syn could interact with mitochondrial DNA (mtDNA) directly or influence RNAs or transcription factors in mitochondria and change the mtDNA transcription profile. In this review, we summarized clues of these possible interactions.

Indexed as

alpha-SynucleinAlzheimer DiseaseAmyloid beta-PeptidesDNA, MitochondrialHumansMitochondriaTranscription Factorsalpha-SynucleinAmyloid beta-PeptidesDNA, MitochondrialTranscription FactorsAlzheimer’s diseaseamyloid βMitochondrial DNAmitochondrial dysfunctionmtDNA transcriptionneurodegenerationParkinson diseaseα-synuclein

Identifiers

PMID36125124
PMCPMC9542719
OpenAlexW4296772687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.